These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38695720)

  • 21. Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial.
    Howard R; Cort E; Bradley R; Harper E; Kelly L; Bentham P; Ritchie C; Reeves S; Fawzi W; Livingston G; Sommerlad A; Oomman S; Nazir E; Nilforooshan R; Barber R; Fox C; Macharouthu AV; Ramachandra P; Pattan V; Sykes J; Curran V; Katona C; Dening T; Knapp M; Gray R;
    Lancet Psychiatry; 2018 Jul; 5(7):553-563. PubMed ID: 29880238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second-generation antipsychotic medications and risk of pneumonia in schizophrenia.
    Kuo CJ; Yang SY; Liao YT; Chen WJ; Lee WC; Shau WY; Chang YT; Tsai SY; Chen CC
    Schizophr Bull; 2013 May; 39(3):648-57. PubMed ID: 22282455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine.
    Molina JD; Toledo-Romero F; López-Rodríguez E; Amorin-Díaz M; Lerma-Carrillo I; López-Muñoz F
    Pharmacopsychiatry; 2011 Jun; 44(4):142-7. PubMed ID: 21710404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing the Antipsychotic in Early Nonimprovers to Amisulpride or Olanzapine: Randomized, Double-Blind Trial in Patients With Schizophrenia.
    Heres S; Cordes J; Feyerabend S; Schmidt-Kraepelin C; Musil R; Riedel M; Spellmann I; Langguth B; Landgrebe M; Fran E; Petcu C C; Hahn E; Ta TMT; Matei V; Dehelean L; Papava I; Leweke FM; van der List T; Tamasan SC; Lang FU; Naber D; Ruhrmann S; Wolff-Menzler C; Juckel G; Ladea M; Stefanescu C; Lautenschlager M; Bauer M; Zamora D; Horowitz M; Davis JM; Leucht S
    Schizophr Bull; 2022 Nov; 48(6):1273-1283. PubMed ID: 35857811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics.
    Cai J; Li L; Shao T; Sun M; Wang W; Xie P; Wang X; Yang Y; Long Y; Kang D; Xiao J; Su Y; Peng X; Huang Y; Gao M; Wu Q; Song C; Liu F; Shao P; Ou J; Shen Y; Huang J; Wu R
    Psychiatry Res; 2023 Apr; 322():115138. PubMed ID: 36871411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What is the "best intro"-explanatory versus pragmatic antipsychotic drug trials.
    Leucht S; Davis JM
    Lancet Psychiatry; 2020 Dec; 7(12):1004-1006. PubMed ID: 33069272
    [No Abstract]   [Full Text] [Related]  

  • 27. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
    Rummel-Kluge C; Komossa K; Schwarz S; Hunger H; Schmid F; Lobos CA; Kissling W; Davis JM; Leucht S
    Schizophr Res; 2010 Nov; 123(2-3):225-33. PubMed ID: 20692814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.
    Mortimer A; Martin S; Lôo H; Peuskens J;
    Int Clin Psychopharmacol; 2004 Mar; 19(2):63-9. PubMed ID: 15076013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risperidone versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Schwarz S; Schmid F; Hunger H; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006626. PubMed ID: 21249678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic control in patients with schizophrenia treated with amisulpride or olanzapine.
    Peuskens J; De Hert M; Mortimer A;
    Int Clin Psychopharmacol; 2007 May; 22(3):145-52. PubMed ID: 17414740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression.
    Vanelle JM; Douki S
    Eur Psychiatry; 2006 Dec; 21(8):523-30. PubMed ID: 17113759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involuntary Facial Twitching in a Patient with Schizophrenia on Treatment with Long Acting Injectable Olanzapine.
    Mustafa FA; Nayar A
    Psychopharmacol Bull; 2019 Jun; 49(2):63-64. PubMed ID: 31308585
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes of Mental State and Serum Prolactin Levels in Patients with Schizophrenia and Depression after Receiving the Combination Therapy of Amisulpride and Chloroprothixol Tablets.
    Yuan B; Yuan M
    Comput Math Methods Med; 2022; 2022():6580030. PubMed ID: 35242209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pragmatic antipsychotics trial-caution in interpretation.
    Baandrup L; Ebdrup BH
    Lancet Psychiatry; 2021 Feb; 8(2):100-101. PubMed ID: 33485409
    [No Abstract]   [Full Text] [Related]  

  • 36. Modeling and Simulation for Individualized Therapy of Amisulpride in Chinese Patients with Schizophrenia: Focus on Interindividual Variability, Therapeutic Reference Range and the Laboratory Alert Level.
    Huang S; Li L; Wang Z; Xiao T; Li X; Liu S; Zhang M; Lu H; Wen Y; Shang D
    Drug Des Devel Ther; 2021; 15():3903-3913. PubMed ID: 34548782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response of Catatonia to Amisulpride and Lorazepam in an Adolescent with Schizophenia.
    Cevher Binici N; Topal Z; Demir Samurcu N; Cansız MA; Savcı U; Öztürk Y; Özyurt G; Tufan AE
    J Child Adolesc Psychopharmacol; 2018 Mar; 28(2):151-152. PubMed ID: 29406775
    [No Abstract]   [Full Text] [Related]  

  • 38. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
    Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of rechallenge clozapine after agranulocytosis: A case report.
    Roméo B; Petillion A; Martelli C; Benyamina A
    Encephale; 2019 Nov; 45(5):449-450. PubMed ID: 30878138
    [No Abstract]   [Full Text] [Related]  

  • 40. Restless Legs Syndrome and Schizophrenia: A Case Report.
    Colle R; Boichot F; Bouteiller E; Elie-Lefebvre C; Hardy P; David DJ; Verstuyft C; Corruble E
    J Clin Psychopharmacol; 2018 Feb; 38(1):91-92. PubMed ID: 29215385
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.